Table 4

Risk of death from CRC in patients receiving chemotherapy versus those receiving surgery alone in sex, p53, and MSI subgroups

Females HRa (95% CI)Males HR (95% CI)
p53 normal
 MSI+0.13 (0.02–0.65)0.28 (0.06–1.15)
 MSI−0.26 (0.16–0.42)0.58 (0.36–0.93)
p53 mutant
 MSI+0.22 (0.04–1.23)0.50 (0.09–2.73)
 MSI−0.46 (0.28–0.76)1.02 (0.64–1.62)
  • a HR, hazard ratio.